Global Clinical Research Organisation (CRO) Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Clinical Research Organisation (CRO) Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Page: 122

Published Date: 01 Sep 2023

Category: Service & Software

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

According to our (Global Info Research) latest study, the global Clinical Research Organisation (CRO) market size was valued at USD 14590 million in 2022 and is forecast to a readjusted size of USD 20900 million by 2029 with a CAGR of 5.3% during review period.

The global Clinical Research Organization (CRO) market is experiencing rapid growth due to the increasing complexity of clinical trials, rising demand for innovative therapies, and outsourcing trends in the pharmaceutical industry. CROs play a critical role in driving drug development and providing comprehensive services throughout the entire clinical research process. As the healthcare landscape evolves, the market for CROs is expected to expand further, driven by advancements in technology, personalized medicine initiatives, and the globalization of clinical trials.

The Global Info Research report includes an overview of the development of the Clinical Research Organisation (CRO) industry chain, the market status of Pharmaceutical Company (Small molecules, Biologics), Research Institute (Small molecules, Biologics), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Clinical Research Organisation (CRO).

Regionally, the report analyzes the Clinical Research Organisation (CRO) markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Clinical Research Organisation (CRO) market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Clinical Research Organisation (CRO) market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Clinical Research Organisation (CRO) industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Small molecules, Biologics).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Clinical Research Organisation (CRO) market.

Regional Analysis: The report involves examining the Clinical Research Organisation (CRO) market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Clinical Research Organisation (CRO) market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Clinical Research Organisation (CRO):
Company Analysis: Report covers individual Clinical Research Organisation (CRO) players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Clinical Research Organisation (CRO) This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Pharmaceutical Company, Research Institute).

Technology Analysis: Report covers specific technologies relevant to Clinical Research Organisation (CRO). It assesses the current state, advancements, and potential future developments in Clinical Research Organisation (CRO) areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Clinical Research Organisation (CRO) market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Clinical Research Organisation (CRO) market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
Small molecules
Biologics

Market segment by Application
Pharmaceutical Company
Research Institute
Other

Market segment by players, this report covers
Charles River Laboratories
IQVIA
LabCorp
Domainex
Evotec AG
Genscript Biotech
GVK Biosciences
Aurobindo Pharma
Eurofins Scientific
Reprocell
Dalton Pharma
NovAliX
Jubilant Biosys
Lupin Pharmaceuticals
Piramal Pharma
Sun Pharmaceutical
Sai Ganga Panakeia
Vitas Pharma
Pharmaron Beijing
WuXi AppTec
Asymchem Laboratories
Porton Pharma
ChemPartner
Hangzhou Tigermed

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Clinical Research Organisation (CRO) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Clinical Research Organisation (CRO), with revenue, gross margin and global market share of Clinical Research Organisation (CRO) from 2018 to 2023.
Chapter 3, the Clinical Research Organisation (CRO) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Clinical Research Organisation (CRO) market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Clinical Research Organisation (CRO).
Chapter 13, to describe Clinical Research Organisation (CRO) research findings and conclusion.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Clinical Research Organisation (CRO)
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Clinical Research Organisation (CRO) by Type
1.3.1 Overview: Global Clinical Research Organisation (CRO) Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Clinical Research Organisation (CRO) Consumption Value Market Share by Type in 2022
1.3.3 Small molecules
1.3.4 Biologics
1.4 Global Clinical Research Organisation (CRO) Market by Application
1.4.1 Overview: Global Clinical Research Organisation (CRO) Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Pharmaceutical Company
1.4.3 Research Institute
1.4.4 Other
1.5 Global Clinical Research Organisation (CRO) Market Size & Forecast
1.6 Global Clinical Research Organisation (CRO) Market Size and Forecast by Region
1.6.1 Global Clinical Research Organisation (CRO) Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Clinical Research Organisation (CRO) Market Size by Region, (2018-2029)
1.6.3 North America Clinical Research Organisation (CRO) Market Size and Prospect (2018-2029)
1.6.4 Europe Clinical Research Organisation (CRO) Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Clinical Research Organisation (CRO) Market Size and Prospect (2018-2029)
1.6.6 South America Clinical Research Organisation (CRO) Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Clinical Research Organisation (CRO) Market Size and Prospect (2018-2029)

2 Company Profiles
2.1 Charles River Laboratories
2.1.1 Charles River Laboratories Details
2.1.2 Charles River Laboratories Major Business
2.1.3 Charles River Laboratories Clinical Research Organisation (CRO) Product and Solutions
2.1.4 Charles River Laboratories Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Charles River Laboratories Recent Developments and Future Plans
2.2 IQVIA
2.2.1 IQVIA Details
2.2.2 IQVIA Major Business
2.2.3 IQVIA Clinical Research Organisation (CRO) Product and Solutions
2.2.4 IQVIA Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 IQVIA Recent Developments and Future Plans
2.3 LabCorp
2.3.1 LabCorp Details
2.3.2 LabCorp Major Business
2.3.3 LabCorp Clinical Research Organisation (CRO) Product and Solutions
2.3.4 LabCorp Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 LabCorp Recent Developments and Future Plans
2.4 Domainex
2.4.1 Domainex Details
2.4.2 Domainex Major Business
2.4.3 Domainex Clinical Research Organisation (CRO) Product and Solutions
2.4.4 Domainex Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Domainex Recent Developments and Future Plans
2.5 Evotec AG
2.5.1 Evotec AG Details
2.5.2 Evotec AG Major Business
2.5.3 Evotec AG Clinical Research Organisation (CRO) Product and Solutions
2.5.4 Evotec AG Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Evotec AG Recent Developments and Future Plans
2.6 Genscript Biotech
2.6.1 Genscript Biotech Details
2.6.2 Genscript Biotech Major Business
2.6.3 Genscript Biotech Clinical Research Organisation (CRO) Product and Solutions
2.6.4 Genscript Biotech Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Genscript Biotech Recent Developments and Future Plans
2.7 GVK Biosciences
2.7.1 GVK Biosciences Details
2.7.2 GVK Biosciences Major Business
2.7.3 GVK Biosciences Clinical Research Organisation (CRO) Product and Solutions
2.7.4 GVK Biosciences Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 GVK Biosciences Recent Developments and Future Plans
2.8 Aurobindo Pharma
2.8.1 Aurobindo Pharma Details
2.8.2 Aurobindo Pharma Major Business
2.8.3 Aurobindo Pharma Clinical Research Organisation (CRO) Product and Solutions
2.8.4 Aurobindo Pharma Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Aurobindo Pharma Recent Developments and Future Plans
2.9 Eurofins Scientific
2.9.1 Eurofins Scientific Details
2.9.2 Eurofins Scientific Major Business
2.9.3 Eurofins Scientific Clinical Research Organisation (CRO) Product and Solutions
2.9.4 Eurofins Scientific Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Eurofins Scientific Recent Developments and Future Plans
2.10 Reprocell
2.10.1 Reprocell Details
2.10.2 Reprocell Major Business
2.10.3 Reprocell Clinical Research Organisation (CRO) Product and Solutions
2.10.4 Reprocell Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Reprocell Recent Developments and Future Plans
2.11 Dalton Pharma
2.11.1 Dalton Pharma Details
2.11.2 Dalton Pharma Major Business
2.11.3 Dalton Pharma Clinical Research Organisation (CRO) Product and Solutions
2.11.4 Dalton Pharma Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Dalton Pharma Recent Developments and Future Plans
2.12 NovAliX
2.12.1 NovAliX Details
2.12.2 NovAliX Major Business
2.12.3 NovAliX Clinical Research Organisation (CRO) Product and Solutions
2.12.4 NovAliX Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 NovAliX Recent Developments and Future Plans
2.13 Jubilant Biosys
2.13.1 Jubilant Biosys Details
2.13.2 Jubilant Biosys Major Business
2.13.3 Jubilant Biosys Clinical Research Organisation (CRO) Product and Solutions
2.13.4 Jubilant Biosys Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Jubilant Biosys Recent Developments and Future Plans
2.14 Lupin Pharmaceuticals
2.14.1 Lupin Pharmaceuticals Details
2.14.2 Lupin Pharmaceuticals Major Business
2.14.3 Lupin Pharmaceuticals Clinical Research Organisation (CRO) Product and Solutions
2.14.4 Lupin Pharmaceuticals Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Lupin Pharmaceuticals Recent Developments and Future Plans
2.15 Piramal Pharma
2.15.1 Piramal Pharma Details
2.15.2 Piramal Pharma Major Business
2.15.3 Piramal Pharma Clinical Research Organisation (CRO) Product and Solutions
2.15.4 Piramal Pharma Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Piramal Pharma Recent Developments and Future Plans
2.16 Sun Pharmaceutical
2.16.1 Sun Pharmaceutical Details
2.16.2 Sun Pharmaceutical Major Business
2.16.3 Sun Pharmaceutical Clinical Research Organisation (CRO) Product and Solutions
2.16.4 Sun Pharmaceutical Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Sun Pharmaceutical Recent Developments and Future Plans
2.17 Sai Ganga Panakeia
2.17.1 Sai Ganga Panakeia Details
2.17.2 Sai Ganga Panakeia Major Business
2.17.3 Sai Ganga Panakeia Clinical Research Organisation (CRO) Product and Solutions
2.17.4 Sai Ganga Panakeia Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Sai Ganga Panakeia Recent Developments and Future Plans
2.18 Vitas Pharma
2.18.1 Vitas Pharma Details
2.18.2 Vitas Pharma Major Business
2.18.3 Vitas Pharma Clinical Research Organisation (CRO) Product and Solutions
2.18.4 Vitas Pharma Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Vitas Pharma Recent Developments and Future Plans
2.19 Pharmaron Beijing
2.19.1 Pharmaron Beijing Details
2.19.2 Pharmaron Beijing Major Business
2.19.3 Pharmaron Beijing Clinical Research Organisation (CRO) Product and Solutions
2.19.4 Pharmaron Beijing Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Pharmaron Beijing Recent Developments and Future Plans
2.20 WuXi AppTec
2.20.1 WuXi AppTec Details
2.20.2 WuXi AppTec Major Business
2.20.3 WuXi AppTec Clinical Research Organisation (CRO) Product and Solutions
2.20.4 WuXi AppTec Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 WuXi AppTec Recent Developments and Future Plans
2.21 Asymchem Laboratories
2.21.1 Asymchem Laboratories Details
2.21.2 Asymchem Laboratories Major Business
2.21.3 Asymchem Laboratories Clinical Research Organisation (CRO) Product and Solutions
2.21.4 Asymchem Laboratories Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2018-2023)
2.21.5 Asymchem Laboratories Recent Developments and Future Plans
2.22 Porton Pharma
2.22.1 Porton Pharma Details
2.22.2 Porton Pharma Major Business
2.22.3 Porton Pharma Clinical Research Organisation (CRO) Product and Solutions
2.22.4 Porton Pharma Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2018-2023)
2.22.5 Porton Pharma Recent Developments and Future Plans
2.23 ChemPartner
2.23.1 ChemPartner Details
2.23.2 ChemPartner Major Business
2.23.3 ChemPartner Clinical Research Organisation (CRO) Product and Solutions
2.23.4 ChemPartner Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2018-2023)
2.23.5 ChemPartner Recent Developments and Future Plans
2.24 Hangzhou Tigermed
2.24.1 Hangzhou Tigermed Details
2.24.2 Hangzhou Tigermed Major Business
2.24.3 Hangzhou Tigermed Clinical Research Organisation (CRO) Product and Solutions
2.24.4 Hangzhou Tigermed Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2018-2023)
2.24.5 Hangzhou Tigermed Recent Developments and Future Plans

3 Market Competition, by Players
3.1 Global Clinical Research Organisation (CRO) Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Clinical Research Organisation (CRO) by Company Revenue
3.2.2 Top 3 Clinical Research Organisation (CRO) Players Market Share in 2022
3.2.3 Top 6 Clinical Research Organisation (CRO) Players Market Share in 2022
3.3 Clinical Research Organisation (CRO) Market: Overall Company Footprint Analysis
3.3.1 Clinical Research Organisation (CRO) Market: Region Footprint
3.3.2 Clinical Research Organisation (CRO) Market: Company Product Type Footprint
3.3.3 Clinical Research Organisation (CRO) Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
4.1 Global Clinical Research Organisation (CRO) Consumption Value and Market Share by Type (2018-2023)
4.2 Global Clinical Research Organisation (CRO) Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
5.1 Global Clinical Research Organisation (CRO) Consumption Value Market Share by Application (2018-2023)
5.2 Global Clinical Research Organisation (CRO) Market Forecast by Application (2024-2029)

6 North America
6.1 North America Clinical Research Organisation (CRO) Consumption Value by Type (2018-2029)
6.2 North America Clinical Research Organisation (CRO) Consumption Value by Application (2018-2029)
6.3 North America Clinical Research Organisation (CRO) Market Size by Country
6.3.1 North America Clinical Research Organisation (CRO) Consumption Value by Country (2018-2029)
6.3.2 United States Clinical Research Organisation (CRO) Market Size and Forecast (2018-2029)
6.3.3 Canada Clinical Research Organisation (CRO) Market Size and Forecast (2018-2029)
6.3.4 Mexico Clinical Research Organisation (CRO) Market Size and Forecast (2018-2029)

7 Europe
7.1 Europe Clinical Research Organisation (CRO) Consumption Value by Type (2018-2029)
7.2 Europe Clinical Research Organisation (CRO) Consumption Value by Application (2018-2029)
7.3 Europe Clinical Research Organisation (CRO) Market Size by Country
7.3.1 Europe Clinical Research Organisation (CRO) Consumption Value by Country (2018-2029)
7.3.2 Germany Clinical Research Organisation (CRO) Market Size and Forecast (2018-2029)
7.3.3 France Clinical Research Organisation (CRO) Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Clinical Research Organisation (CRO) Market Size and Forecast (2018-2029)
7.3.5 Russia Clinical Research Organisation (CRO) Market Size and Forecast (2018-2029)
7.3.6 Italy Clinical Research Organisation (CRO) Market Size and Forecast (2018-2029)

8 Asia-Pacific
8.1 Asia-Pacific Clinical Research Organisation (CRO) Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Clinical Research Organisation (CRO) Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Clinical Research Organisation (CRO) Market Size by Region
8.3.1 Asia-Pacific Clinical Research Organisation (CRO) Consumption Value by Region (2018-2029)
8.3.2 China Clinical Research Organisation (CRO) Market Size and Forecast (2018-2029)
8.3.3 Japan Clinical Research Organisation (CRO) Market Size and Forecast (2018-2029)
8.3.4 South Korea Clinical Research Organisation (CRO) Market Size and Forecast (2018-2029)
8.3.5 India Clinical Research Organisation (CRO) Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Clinical Research Organisation (CRO) Market Size and Forecast (2018-2029)
8.3.7 Australia Clinical Research Organisation (CRO) Market Size and Forecast (2018-2029)

9 South America
9.1 South America Clinical Research Organisation (CRO) Consumption Value by Type (2018-2029)
9.2 South America Clinical Research Organisation (CRO) Consumption Value by Application (2018-2029)
9.3 South America Clinical Research Organisation (CRO) Market Size by Country
9.3.1 South America Clinical Research Organisation (CRO) Consumption Value by Country (2018-2029)
9.3.2 Brazil Clinical Research Organisation (CRO) Market Size and Forecast (2018-2029)
9.3.3 Argentina Clinical Research Organisation (CRO) Market Size and Forecast (2018-2029)

10 Middle East & Africa
10.1 Middle East & Africa Clinical Research Organisation (CRO) Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Clinical Research Organisation (CRO) Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Clinical Research Organisation (CRO) Market Size by Country
10.3.1 Middle East & Africa Clinical Research Organisation (CRO) Consumption Value by Country (2018-2029)
10.3.2 Turkey Clinical Research Organisation (CRO) Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Clinical Research Organisation (CRO) Market Size and Forecast (2018-2029)
10.3.4 UAE Clinical Research Organisation (CRO) Market Size and Forecast (2018-2029)

11 Market Dynamics
11.1 Clinical Research Organisation (CRO) Market Drivers
11.2 Clinical Research Organisation (CRO) Market Restraints
11.3 Clinical Research Organisation (CRO) Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry

12 Industry Chain Analysis
12.1 Clinical Research Organisation (CRO) Industry Chain
12.2 Clinical Research Organisation (CRO) Upstream Analysis
12.3 Clinical Research Organisation (CRO) Midstream Analysis
12.4 Clinical Research Organisation (CRO) Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Clinical Research Organisation (CRO) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Clinical Research Organisation (CRO) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Clinical Research Organisation (CRO) Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Clinical Research Organisation (CRO) Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Charles River Laboratories Company Information, Head Office, and Major Competitors
Table 6. Charles River Laboratories Major Business
Table 7. Charles River Laboratories Clinical Research Organisation (CRO) Product and Solutions
Table 8. Charles River Laboratories Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Charles River Laboratories Recent Developments and Future Plans
Table 10. IQVIA Company Information, Head Office, and Major Competitors
Table 11. IQVIA Major Business
Table 12. IQVIA Clinical Research Organisation (CRO) Product and Solutions
Table 13. IQVIA Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. IQVIA Recent Developments and Future Plans
Table 15. LabCorp Company Information, Head Office, and Major Competitors
Table 16. LabCorp Major Business
Table 17. LabCorp Clinical Research Organisation (CRO) Product and Solutions
Table 18. LabCorp Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. LabCorp Recent Developments and Future Plans
Table 20. Domainex Company Information, Head Office, and Major Competitors
Table 21. Domainex Major Business
Table 22. Domainex Clinical Research Organisation (CRO) Product and Solutions
Table 23. Domainex Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Domainex Recent Developments and Future Plans
Table 25. Evotec AG Company Information, Head Office, and Major Competitors
Table 26. Evotec AG Major Business
Table 27. Evotec AG Clinical Research Organisation (CRO) Product and Solutions
Table 28. Evotec AG Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Evotec AG Recent Developments and Future Plans
Table 30. Genscript Biotech Company Information, Head Office, and Major Competitors
Table 31. Genscript Biotech Major Business
Table 32. Genscript Biotech Clinical Research Organisation (CRO) Product and Solutions
Table 33. Genscript Biotech Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Genscript Biotech Recent Developments and Future Plans
Table 35. GVK Biosciences Company Information, Head Office, and Major Competitors
Table 36. GVK Biosciences Major Business
Table 37. GVK Biosciences Clinical Research Organisation (CRO) Product and Solutions
Table 38. GVK Biosciences Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. GVK Biosciences Recent Developments and Future Plans
Table 40. Aurobindo Pharma Company Information, Head Office, and Major Competitors
Table 41. Aurobindo Pharma Major Business
Table 42. Aurobindo Pharma Clinical Research Organisation (CRO) Product and Solutions
Table 43. Aurobindo Pharma Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Aurobindo Pharma Recent Developments and Future Plans
Table 45. Eurofins Scientific Company Information, Head Office, and Major Competitors
Table 46. Eurofins Scientific Major Business
Table 47. Eurofins Scientific Clinical Research Organisation (CRO) Product and Solutions
Table 48. Eurofins Scientific Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Eurofins Scientific Recent Developments and Future Plans
Table 50. Reprocell Company Information, Head Office, and Major Competitors
Table 51. Reprocell Major Business
Table 52. Reprocell Clinical Research Organisation (CRO) Product and Solutions
Table 53. Reprocell Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Reprocell Recent Developments and Future Plans
Table 55. Dalton Pharma Company Information, Head Office, and Major Competitors
Table 56. Dalton Pharma Major Business
Table 57. Dalton Pharma Clinical Research Organisation (CRO) Product and Solutions
Table 58. Dalton Pharma Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Dalton Pharma Recent Developments and Future Plans
Table 60. NovAliX Company Information, Head Office, and Major Competitors
Table 61. NovAliX Major Business
Table 62. NovAliX Clinical Research Organisation (CRO) Product and Solutions
Table 63. NovAliX Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. NovAliX Recent Developments and Future Plans
Table 65. Jubilant Biosys Company Information, Head Office, and Major Competitors
Table 66. Jubilant Biosys Major Business
Table 67. Jubilant Biosys Clinical Research Organisation (CRO) Product and Solutions
Table 68. Jubilant Biosys Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Jubilant Biosys Recent Developments and Future Plans
Table 70. Lupin Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 71. Lupin Pharmaceuticals Major Business
Table 72. Lupin Pharmaceuticals Clinical Research Organisation (CRO) Product and Solutions
Table 73. Lupin Pharmaceuticals Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Lupin Pharmaceuticals Recent Developments and Future Plans
Table 75. Piramal Pharma Company Information, Head Office, and Major Competitors
Table 76. Piramal Pharma Major Business
Table 77. Piramal Pharma Clinical Research Organisation (CRO) Product and Solutions
Table 78. Piramal Pharma Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Piramal Pharma Recent Developments and Future Plans
Table 80. Sun Pharmaceutical Company Information, Head Office, and Major Competitors
Table 81. Sun Pharmaceutical Major Business
Table 82. Sun Pharmaceutical Clinical Research Organisation (CRO) Product and Solutions
Table 83. Sun Pharmaceutical Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Sun Pharmaceutical Recent Developments and Future Plans
Table 85. Sai Ganga Panakeia Company Information, Head Office, and Major Competitors
Table 86. Sai Ganga Panakeia Major Business
Table 87. Sai Ganga Panakeia Clinical Research Organisation (CRO) Product and Solutions
Table 88. Sai Ganga Panakeia Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Sai Ganga Panakeia Recent Developments and Future Plans
Table 90. Vitas Pharma Company Information, Head Office, and Major Competitors
Table 91. Vitas Pharma Major Business
Table 92. Vitas Pharma Clinical Research Organisation (CRO) Product and Solutions
Table 93. Vitas Pharma Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. Vitas Pharma Recent Developments and Future Plans
Table 95. Pharmaron Beijing Company Information, Head Office, and Major Competitors
Table 96. Pharmaron Beijing Major Business
Table 97. Pharmaron Beijing Clinical Research Organisation (CRO) Product and Solutions
Table 98. Pharmaron Beijing Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 99. Pharmaron Beijing Recent Developments and Future Plans
Table 100. WuXi AppTec Company Information, Head Office, and Major Competitors
Table 101. WuXi AppTec Major Business
Table 102. WuXi AppTec Clinical Research Organisation (CRO) Product and Solutions
Table 103. WuXi AppTec Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 104. WuXi AppTec Recent Developments and Future Plans
Table 105. Asymchem Laboratories Company Information, Head Office, and Major Competitors
Table 106. Asymchem Laboratories Major Business
Table 107. Asymchem Laboratories Clinical Research Organisation (CRO) Product and Solutions
Table 108. Asymchem Laboratories Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 109. Asymchem Laboratories Recent Developments and Future Plans
Table 110. Porton Pharma Company Information, Head Office, and Major Competitors
Table 111. Porton Pharma Major Business
Table 112. Porton Pharma Clinical Research Organisation (CRO) Product and Solutions
Table 113. Porton Pharma Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 114. Porton Pharma Recent Developments and Future Plans
Table 115. ChemPartner Company Information, Head Office, and Major Competitors
Table 116. ChemPartner Major Business
Table 117. ChemPartner Clinical Research Organisation (CRO) Product and Solutions
Table 118. ChemPartner Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. ChemPartner Recent Developments and Future Plans
Table 120. Hangzhou Tigermed Company Information, Head Office, and Major Competitors
Table 121. Hangzhou Tigermed Major Business
Table 122. Hangzhou Tigermed Clinical Research Organisation (CRO) Product and Solutions
Table 123. Hangzhou Tigermed Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 124. Hangzhou Tigermed Recent Developments and Future Plans
Table 125. Global Clinical Research Organisation (CRO) Revenue (USD Million) by Players (2018-2023)
Table 126. Global Clinical Research Organisation (CRO) Revenue Share by Players (2018-2023)
Table 127. Breakdown of Clinical Research Organisation (CRO) by Company Type (Tier 1, Tier 2, and Tier 3)
Table 128. Market Position of Players in Clinical Research Organisation (CRO), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 129. Head Office of Key Clinical Research Organisation (CRO) Players
Table 130. Clinical Research Organisation (CRO) Market: Company Product Type Footprint
Table 131. Clinical Research Organisation (CRO) Market: Company Product Application Footprint
Table 132. Clinical Research Organisation (CRO) New Market Entrants and Barriers to Market Entry
Table 133. Clinical Research Organisation (CRO) Mergers, Acquisition, Agreements, and Collaborations
Table 134. Global Clinical Research Organisation (CRO) Consumption Value (USD Million) by Type (2018-2023)
Table 135. Global Clinical Research Organisation (CRO) Consumption Value Share by Type (2018-2023)
Table 136. Global Clinical Research Organisation (CRO) Consumption Value Forecast by Type (2024-2029)
Table 137. Global Clinical Research Organisation (CRO) Consumption Value by Application (2018-2023)
Table 138. Global Clinical Research Organisation (CRO) Consumption Value Forecast by Application (2024-2029)
Table 139. North America Clinical Research Organisation (CRO) Consumption Value by Type (2018-2023) & (USD Million)
Table 140. North America Clinical Research Organisation (CRO) Consumption Value by Type (2024-2029) & (USD Million)
Table 141. North America Clinical Research Organisation (CRO) Consumption Value by Application (2018-2023) & (USD Million)
Table 142. North America Clinical Research Organisation (CRO) Consumption Value by Application (2024-2029) & (USD Million)
Table 143. North America Clinical Research Organisation (CRO) Consumption Value by Country (2018-2023) & (USD Million)
Table 144. North America Clinical Research Organisation (CRO) Consumption Value by Country (2024-2029) & (USD Million)
Table 145. Europe Clinical Research Organisation (CRO) Consumption Value by Type (2018-2023) & (USD Million)
Table 146. Europe Clinical Research Organisation (CRO) Consumption Value by Type (2024-2029) & (USD Million)
Table 147. Europe Clinical Research Organisation (CRO) Consumption Value by Application (2018-2023) & (USD Million)
Table 148. Europe Clinical Research Organisation (CRO) Consumption Value by Application (2024-2029) & (USD Million)
Table 149. Europe Clinical Research Organisation (CRO) Consumption Value by Country (2018-2023) & (USD Million)
Table 150. Europe Clinical Research Organisation (CRO) Consumption Value by Country (2024-2029) & (USD Million)
Table 151. Asia-Pacific Clinical Research Organisation (CRO) Consumption Value by Type (2018-2023) & (USD Million)
Table 152. Asia-Pacific Clinical Research Organisation (CRO) Consumption Value by Type (2024-2029) & (USD Million)
Table 153. Asia-Pacific Clinical Research Organisation (CRO) Consumption Value by Application (2018-2023) & (USD Million)
Table 154. Asia-Pacific Clinical Research Organisation (CRO) Consumption Value by Application (2024-2029) & (USD Million)
Table 155. Asia-Pacific Clinical Research Organisation (CRO) Consumption Value by Region (2018-2023) & (USD Million)
Table 156. Asia-Pacific Clinical Research Organisation (CRO) Consumption Value by Region (2024-2029) & (USD Million)
Table 157. South America Clinical Research Organisation (CRO) Consumption Value by Type (2018-2023) & (USD Million)
Table 158. South America Clinical Research Organisation (CRO) Consumption Value by Type (2024-2029) & (USD Million)
Table 159. South America Clinical Research Organisation (CRO) Consumption Value by Application (2018-2023) & (USD Million)
Table 160. South America Clinical Research Organisation (CRO) Consumption Value by Application (2024-2029) & (USD Million)
Table 161. South America Clinical Research Organisation (CRO) Consumption Value by Country (2018-2023) & (USD Million)
Table 162. South America Clinical Research Organisation (CRO) Consumption Value by Country (2024-2029) & (USD Million)
Table 163. Middle East & Africa Clinical Research Organisation (CRO) Consumption Value by Type (2018-2023) & (USD Million)
Table 164. Middle East & Africa Clinical Research Organisation (CRO) Consumption Value by Type (2024-2029) & (USD Million)
Table 165. Middle East & Africa Clinical Research Organisation (CRO) Consumption Value by Application (2018-2023) & (USD Million)
Table 166. Middle East & Africa Clinical Research Organisation (CRO) Consumption Value by Application (2024-2029) & (USD Million)
Table 167. Middle East & Africa Clinical Research Organisation (CRO) Consumption Value by Country (2018-2023) & (USD Million)
Table 168. Middle East & Africa Clinical Research Organisation (CRO) Consumption Value by Country (2024-2029) & (USD Million)
Table 169. Clinical Research Organisation (CRO) Raw Material
Table 170. Key Suppliers of Clinical Research Organisation (CRO) Raw Materials
List of Figures
Figure 1. Clinical Research Organisation (CRO) Picture
Figure 2. Global Clinical Research Organisation (CRO) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Clinical Research Organisation (CRO) Consumption Value Market Share by Type in 2022
Figure 4. Small molecules
Figure 5. Biologics
Figure 6. Global Clinical Research Organisation (CRO) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Clinical Research Organisation (CRO) Consumption Value Market Share by Application in 2022
Figure 8. Pharmaceutical Company Picture
Figure 9. Research Institute Picture
Figure 10. Other Picture
Figure 11. Global Clinical Research Organisation (CRO) Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Clinical Research Organisation (CRO) Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Market Clinical Research Organisation (CRO) Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 14. Global Clinical Research Organisation (CRO) Consumption Value Market Share by Region (2018-2029)
Figure 15. Global Clinical Research Organisation (CRO) Consumption Value Market Share by Region in 2022
Figure 16. North America Clinical Research Organisation (CRO) Consumption Value (2018-2029) & (USD Million)
Figure 17. Europe Clinical Research Organisation (CRO) Consumption Value (2018-2029) & (USD Million)
Figure 18. Asia-Pacific Clinical Research Organisation (CRO) Consumption Value (2018-2029) & (USD Million)
Figure 19. South America Clinical Research Organisation (CRO) Consumption Value (2018-2029) & (USD Million)
Figure 20. Middle East and Africa Clinical Research Organisation (CRO) Consumption Value (2018-2029) & (USD Million)
Figure 21. Global Clinical Research Organisation (CRO) Revenue Share by Players in 2022
Figure 22. Clinical Research Organisation (CRO) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 23. Global Top 3 Players Clinical Research Organisation (CRO) Market Share in 2022
Figure 24. Global Top 6 Players Clinical Research Organisation (CRO) Market Share in 2022
Figure 25. Global Clinical Research Organisation (CRO) Consumption Value Share by Type (2018-2023)
Figure 26. Global Clinical Research Organisation (CRO) Market Share Forecast by Type (2024-2029)
Figure 27. Global Clinical Research Organisation (CRO) Consumption Value Share by Application (2018-2023)
Figure 28. Global Clinical Research Organisation (CRO) Market Share Forecast by Application (2024-2029)
Figure 29. North America Clinical Research Organisation (CRO) Consumption Value Market Share by Type (2018-2029)
Figure 30. North America Clinical Research Organisation (CRO) Consumption Value Market Share by Application (2018-2029)
Figure 31. North America Clinical Research Organisation (CRO) Consumption Value Market Share by Country (2018-2029)
Figure 32. United States Clinical Research Organisation (CRO) Consumption Value (2018-2029) & (USD Million)
Figure 33. Canada Clinical Research Organisation (CRO) Consumption Value (2018-2029) & (USD Million)
Figure 34. Mexico Clinical Research Organisation (CRO) Consumption Value (2018-2029) & (USD Million)
Figure 35. Europe Clinical Research Organisation (CRO) Consumption Value Market Share by Type (2018-2029)
Figure 36. Europe Clinical Research Organisation (CRO) Consumption Value Market Share by Application (2018-2029)
Figure 37. Europe Clinical Research Organisation (CRO) Consumption Value Market Share by Country (2018-2029)
Figure 38. Germany Clinical Research Organisation (CRO) Consumption Value (2018-2029) & (USD Million)
Figure 39. France Clinical Research Organisation (CRO) Consumption Value (2018-2029) & (USD Million)
Figure 40. United Kingdom Clinical Research Organisation (CRO) Consumption Value (2018-2029) & (USD Million)
Figure 41. Russia Clinical Research Organisation (CRO) Consumption Value (2018-2029) & (USD Million)
Figure 42. Italy Clinical Research Organisation (CRO) Consumption Value (2018-2029) & (USD Million)
Figure 43. Asia-Pacific Clinical Research Organisation (CRO) Consumption Value Market Share by Type (2018-2029)
Figure 44. Asia-Pacific Clinical Research Organisation (CRO) Consumption Value Market Share by Application (2018-2029)
Figure 45. Asia-Pacific Clinical Research Organisation (CRO) Consumption Value Market Share by Region (2018-2029)
Figure 46. China Clinical Research Organisation (CRO) Consumption Value (2018-2029) & (USD Million)
Figure 47. Japan Clinical Research Organisation (CRO) Consumption Value (2018-2029) & (USD Million)
Figure 48. South Korea Clinical Research Organisation (CRO) Consumption Value (2018-2029) & (USD Million)
Figure 49. India Clinical Research Organisation (CRO) Consumption Value (2018-2029) & (USD Million)
Figure 50. Southeast Asia Clinical Research Organisation (CRO) Consumption Value (2018-2029) & (USD Million)
Figure 51. Australia Clinical Research Organisation (CRO) Consumption Value (2018-2029) & (USD Million)
Figure 52. South America Clinical Research Organisation (CRO) Consumption Value Market Share by Type (2018-2029)
Figure 53. South America Clinical Research Organisation (CRO) Consumption Value Market Share by Application (2018-2029)
Figure 54. South America Clinical Research Organisation (CRO) Consumption Value Market Share by Country (2018-2029)
Figure 55. Brazil Clinical Research Organisation (CRO) Consumption Value (2018-2029) & (USD Million)
Figure 56. Argentina Clinical Research Organisation (CRO) Consumption Value (2018-2029) & (USD Million)
Figure 57. Middle East and Africa Clinical Research Organisation (CRO) Consumption Value Market Share by Type (2018-2029)
Figure 58. Middle East and Africa Clinical Research Organisation (CRO) Consumption Value Market Share by Application (2018-2029)
Figure 59. Middle East and Africa Clinical Research Organisation (CRO) Consumption Value Market Share by Country (2018-2029)
Figure 60. Turkey Clinical Research Organisation (CRO) Consumption Value (2018-2029) & (USD Million)
Figure 61. Saudi Arabia Clinical Research Organisation (CRO) Consumption Value (2018-2029) & (USD Million)
Figure 62. UAE Clinical Research Organisation (CRO) Consumption Value (2018-2029) & (USD Million)
Figure 63. Clinical Research Organisation (CRO) Market Drivers
Figure 64. Clinical Research Organisation (CRO) Market Restraints
Figure 65. Clinical Research Organisation (CRO) Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Clinical Research Organisation (CRO) in 2022
Figure 68. Manufacturing Process Analysis of Clinical Research Organisation (CRO)
Figure 69. Clinical Research Organisation (CRO) Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Charles River Laboratories
IQVIA
LabCorp
Domainex
Evotec AG
Genscript Biotech
GVK Biosciences
Aurobindo Pharma
Eurofins Scientific
Reprocell
Dalton Pharma
NovAliX
Jubilant Biosys
Lupin Pharmaceuticals
Piramal Pharma
Sun Pharmaceutical
Sai Ganga Panakeia
Vitas Pharma
Pharmaron Beijing
WuXi AppTec
Asymchem Laboratories
Porton Pharma
ChemPartner
Hangzhou Tigermed
shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Clinical Research Organisation (CRO) Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Clinical Research Organisation (CRO) Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Page: 122

Published Date: 01 Sep 2023

Category: Service & Software

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

According to our (Global Info Research) latest study, the global Clinical Research Organisation (CRO) market size was valued at USD 14590 million in 2022 and is forecast to a readjusted size of USD 20900 million by 2029 with a CAGR of 5.3% during review period.

The global Clinical Research Organization (CRO) market is experiencing rapid growth due to the increasing complexity of clinical trials, rising demand for innovative therapies, and outsourcing trends in the pharmaceutical industry. CROs play a critical role in driving drug development and providing comprehensive services throughout the entire clinical research process. As the healthcare landscape evolves, the market for CROs is expected to expand further, driven by advancements in technology, personalized medicine initiatives, and the globalization of clinical trials.

The Global Info Research report includes an overview of the development of the Clinical Research Organisation (CRO) industry chain, the market status of Pharmaceutical Company (Small molecules, Biologics), Research Institute (Small molecules, Biologics), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Clinical Research Organisation (CRO).

Regionally, the report analyzes the Clinical Research Organisation (CRO) markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Clinical Research Organisation (CRO) market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Clinical Research Organisation (CRO) market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Clinical Research Organisation (CRO) industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Small molecules, Biologics).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Clinical Research Organisation (CRO) market.

Regional Analysis: The report involves examining the Clinical Research Organisation (CRO) market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Clinical Research Organisation (CRO) market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Clinical Research Organisation (CRO):
Company Analysis: Report covers individual Clinical Research Organisation (CRO) players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Clinical Research Organisation (CRO) This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Pharmaceutical Company, Research Institute).

Technology Analysis: Report covers specific technologies relevant to Clinical Research Organisation (CRO). It assesses the current state, advancements, and potential future developments in Clinical Research Organisation (CRO) areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Clinical Research Organisation (CRO) market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Clinical Research Organisation (CRO) market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
Small molecules
Biologics

Market segment by Application
Pharmaceutical Company
Research Institute
Other

Market segment by players, this report covers
Charles River Laboratories
IQVIA
LabCorp
Domainex
Evotec AG
Genscript Biotech
GVK Biosciences
Aurobindo Pharma
Eurofins Scientific
Reprocell
Dalton Pharma
NovAliX
Jubilant Biosys
Lupin Pharmaceuticals
Piramal Pharma
Sun Pharmaceutical
Sai Ganga Panakeia
Vitas Pharma
Pharmaron Beijing
WuXi AppTec
Asymchem Laboratories
Porton Pharma
ChemPartner
Hangzhou Tigermed

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Clinical Research Organisation (CRO) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Clinical Research Organisation (CRO), with revenue, gross margin and global market share of Clinical Research Organisation (CRO) from 2018 to 2023.
Chapter 3, the Clinical Research Organisation (CRO) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Clinical Research Organisation (CRO) market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Clinical Research Organisation (CRO).
Chapter 13, to describe Clinical Research Organisation (CRO) research findings and conclusion.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Clinical Research Organisation (CRO)
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Clinical Research Organisation (CRO) by Type
1.3.1 Overview: Global Clinical Research Organisation (CRO) Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Clinical Research Organisation (CRO) Consumption Value Market Share by Type in 2022
1.3.3 Small molecules
1.3.4 Biologics
1.4 Global Clinical Research Organisation (CRO) Market by Application
1.4.1 Overview: Global Clinical Research Organisation (CRO) Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Pharmaceutical Company
1.4.3 Research Institute
1.4.4 Other
1.5 Global Clinical Research Organisation (CRO) Market Size & Forecast
1.6 Global Clinical Research Organisation (CRO) Market Size and Forecast by Region
1.6.1 Global Clinical Research Organisation (CRO) Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Clinical Research Organisation (CRO) Market Size by Region, (2018-2029)
1.6.3 North America Clinical Research Organisation (CRO) Market Size and Prospect (2018-2029)
1.6.4 Europe Clinical Research Organisation (CRO) Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Clinical Research Organisation (CRO) Market Size and Prospect (2018-2029)
1.6.6 South America Clinical Research Organisation (CRO) Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Clinical Research Organisation (CRO) Market Size and Prospect (2018-2029)

2 Company Profiles
2.1 Charles River Laboratories
2.1.1 Charles River Laboratories Details
2.1.2 Charles River Laboratories Major Business
2.1.3 Charles River Laboratories Clinical Research Organisation (CRO) Product and Solutions
2.1.4 Charles River Laboratories Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Charles River Laboratories Recent Developments and Future Plans
2.2 IQVIA
2.2.1 IQVIA Details
2.2.2 IQVIA Major Business
2.2.3 IQVIA Clinical Research Organisation (CRO) Product and Solutions
2.2.4 IQVIA Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 IQVIA Recent Developments and Future Plans
2.3 LabCorp
2.3.1 LabCorp Details
2.3.2 LabCorp Major Business
2.3.3 LabCorp Clinical Research Organisation (CRO) Product and Solutions
2.3.4 LabCorp Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 LabCorp Recent Developments and Future Plans
2.4 Domainex
2.4.1 Domainex Details
2.4.2 Domainex Major Business
2.4.3 Domainex Clinical Research Organisation (CRO) Product and Solutions
2.4.4 Domainex Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Domainex Recent Developments and Future Plans
2.5 Evotec AG
2.5.1 Evotec AG Details
2.5.2 Evotec AG Major Business
2.5.3 Evotec AG Clinical Research Organisation (CRO) Product and Solutions
2.5.4 Evotec AG Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Evotec AG Recent Developments and Future Plans
2.6 Genscript Biotech
2.6.1 Genscript Biotech Details
2.6.2 Genscript Biotech Major Business
2.6.3 Genscript Biotech Clinical Research Organisation (CRO) Product and Solutions
2.6.4 Genscript Biotech Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Genscript Biotech Recent Developments and Future Plans
2.7 GVK Biosciences
2.7.1 GVK Biosciences Details
2.7.2 GVK Biosciences Major Business
2.7.3 GVK Biosciences Clinical Research Organisation (CRO) Product and Solutions
2.7.4 GVK Biosciences Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 GVK Biosciences Recent Developments and Future Plans
2.8 Aurobindo Pharma
2.8.1 Aurobindo Pharma Details
2.8.2 Aurobindo Pharma Major Business
2.8.3 Aurobindo Pharma Clinical Research Organisation (CRO) Product and Solutions
2.8.4 Aurobindo Pharma Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Aurobindo Pharma Recent Developments and Future Plans
2.9 Eurofins Scientific
2.9.1 Eurofins Scientific Details
2.9.2 Eurofins Scientific Major Business
2.9.3 Eurofins Scientific Clinical Research Organisation (CRO) Product and Solutions
2.9.4 Eurofins Scientific Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Eurofins Scientific Recent Developments and Future Plans
2.10 Reprocell
2.10.1 Reprocell Details
2.10.2 Reprocell Major Business
2.10.3 Reprocell Clinical Research Organisation (CRO) Product and Solutions
2.10.4 Reprocell Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Reprocell Recent Developments and Future Plans
2.11 Dalton Pharma
2.11.1 Dalton Pharma Details
2.11.2 Dalton Pharma Major Business
2.11.3 Dalton Pharma Clinical Research Organisation (CRO) Product and Solutions
2.11.4 Dalton Pharma Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Dalton Pharma Recent Developments and Future Plans
2.12 NovAliX
2.12.1 NovAliX Details
2.12.2 NovAliX Major Business
2.12.3 NovAliX Clinical Research Organisation (CRO) Product and Solutions
2.12.4 NovAliX Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 NovAliX Recent Developments and Future Plans
2.13 Jubilant Biosys
2.13.1 Jubilant Biosys Details
2.13.2 Jubilant Biosys Major Business
2.13.3 Jubilant Biosys Clinical Research Organisation (CRO) Product and Solutions
2.13.4 Jubilant Biosys Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Jubilant Biosys Recent Developments and Future Plans
2.14 Lupin Pharmaceuticals
2.14.1 Lupin Pharmaceuticals Details
2.14.2 Lupin Pharmaceuticals Major Business
2.14.3 Lupin Pharmaceuticals Clinical Research Organisation (CRO) Product and Solutions
2.14.4 Lupin Pharmaceuticals Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Lupin Pharmaceuticals Recent Developments and Future Plans
2.15 Piramal Pharma
2.15.1 Piramal Pharma Details
2.15.2 Piramal Pharma Major Business
2.15.3 Piramal Pharma Clinical Research Organisation (CRO) Product and Solutions
2.15.4 Piramal Pharma Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Piramal Pharma Recent Developments and Future Plans
2.16 Sun Pharmaceutical
2.16.1 Sun Pharmaceutical Details
2.16.2 Sun Pharmaceutical Major Business
2.16.3 Sun Pharmaceutical Clinical Research Organisation (CRO) Product and Solutions
2.16.4 Sun Pharmaceutical Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Sun Pharmaceutical Recent Developments and Future Plans
2.17 Sai Ganga Panakeia
2.17.1 Sai Ganga Panakeia Details
2.17.2 Sai Ganga Panakeia Major Business
2.17.3 Sai Ganga Panakeia Clinical Research Organisation (CRO) Product and Solutions
2.17.4 Sai Ganga Panakeia Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Sai Ganga Panakeia Recent Developments and Future Plans
2.18 Vitas Pharma
2.18.1 Vitas Pharma Details
2.18.2 Vitas Pharma Major Business
2.18.3 Vitas Pharma Clinical Research Organisation (CRO) Product and Solutions
2.18.4 Vitas Pharma Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Vitas Pharma Recent Developments and Future Plans
2.19 Pharmaron Beijing
2.19.1 Pharmaron Beijing Details
2.19.2 Pharmaron Beijing Major Business
2.19.3 Pharmaron Beijing Clinical Research Organisation (CRO) Product and Solutions
2.19.4 Pharmaron Beijing Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Pharmaron Beijing Recent Developments and Future Plans
2.20 WuXi AppTec
2.20.1 WuXi AppTec Details
2.20.2 WuXi AppTec Major Business
2.20.3 WuXi AppTec Clinical Research Organisation (CRO) Product and Solutions
2.20.4 WuXi AppTec Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 WuXi AppTec Recent Developments and Future Plans
2.21 Asymchem Laboratories
2.21.1 Asymchem Laboratories Details
2.21.2 Asymchem Laboratories Major Business
2.21.3 Asymchem Laboratories Clinical Research Organisation (CRO) Product and Solutions
2.21.4 Asymchem Laboratories Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2018-2023)
2.21.5 Asymchem Laboratories Recent Developments and Future Plans
2.22 Porton Pharma
2.22.1 Porton Pharma Details
2.22.2 Porton Pharma Major Business
2.22.3 Porton Pharma Clinical Research Organisation (CRO) Product and Solutions
2.22.4 Porton Pharma Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2018-2023)
2.22.5 Porton Pharma Recent Developments and Future Plans
2.23 ChemPartner
2.23.1 ChemPartner Details
2.23.2 ChemPartner Major Business
2.23.3 ChemPartner Clinical Research Organisation (CRO) Product and Solutions
2.23.4 ChemPartner Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2018-2023)
2.23.5 ChemPartner Recent Developments and Future Plans
2.24 Hangzhou Tigermed
2.24.1 Hangzhou Tigermed Details
2.24.2 Hangzhou Tigermed Major Business
2.24.3 Hangzhou Tigermed Clinical Research Organisation (CRO) Product and Solutions
2.24.4 Hangzhou Tigermed Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2018-2023)
2.24.5 Hangzhou Tigermed Recent Developments and Future Plans

3 Market Competition, by Players
3.1 Global Clinical Research Organisation (CRO) Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Clinical Research Organisation (CRO) by Company Revenue
3.2.2 Top 3 Clinical Research Organisation (CRO) Players Market Share in 2022
3.2.3 Top 6 Clinical Research Organisation (CRO) Players Market Share in 2022
3.3 Clinical Research Organisation (CRO) Market: Overall Company Footprint Analysis
3.3.1 Clinical Research Organisation (CRO) Market: Region Footprint
3.3.2 Clinical Research Organisation (CRO) Market: Company Product Type Footprint
3.3.3 Clinical Research Organisation (CRO) Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
4.1 Global Clinical Research Organisation (CRO) Consumption Value and Market Share by Type (2018-2023)
4.2 Global Clinical Research Organisation (CRO) Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
5.1 Global Clinical Research Organisation (CRO) Consumption Value Market Share by Application (2018-2023)
5.2 Global Clinical Research Organisation (CRO) Market Forecast by Application (2024-2029)

6 North America
6.1 North America Clinical Research Organisation (CRO) Consumption Value by Type (2018-2029)
6.2 North America Clinical Research Organisation (CRO) Consumption Value by Application (2018-2029)
6.3 North America Clinical Research Organisation (CRO) Market Size by Country
6.3.1 North America Clinical Research Organisation (CRO) Consumption Value by Country (2018-2029)
6.3.2 United States Clinical Research Organisation (CRO) Market Size and Forecast (2018-2029)
6.3.3 Canada Clinical Research Organisation (CRO) Market Size and Forecast (2018-2029)
6.3.4 Mexico Clinical Research Organisation (CRO) Market Size and Forecast (2018-2029)

7 Europe
7.1 Europe Clinical Research Organisation (CRO) Consumption Value by Type (2018-2029)
7.2 Europe Clinical Research Organisation (CRO) Consumption Value by Application (2018-2029)
7.3 Europe Clinical Research Organisation (CRO) Market Size by Country
7.3.1 Europe Clinical Research Organisation (CRO) Consumption Value by Country (2018-2029)
7.3.2 Germany Clinical Research Organisation (CRO) Market Size and Forecast (2018-2029)
7.3.3 France Clinical Research Organisation (CRO) Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Clinical Research Organisation (CRO) Market Size and Forecast (2018-2029)
7.3.5 Russia Clinical Research Organisation (CRO) Market Size and Forecast (2018-2029)
7.3.6 Italy Clinical Research Organisation (CRO) Market Size and Forecast (2018-2029)

8 Asia-Pacific
8.1 Asia-Pacific Clinical Research Organisation (CRO) Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Clinical Research Organisation (CRO) Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Clinical Research Organisation (CRO) Market Size by Region
8.3.1 Asia-Pacific Clinical Research Organisation (CRO) Consumption Value by Region (2018-2029)
8.3.2 China Clinical Research Organisation (CRO) Market Size and Forecast (2018-2029)
8.3.3 Japan Clinical Research Organisation (CRO) Market Size and Forecast (2018-2029)
8.3.4 South Korea Clinical Research Organisation (CRO) Market Size and Forecast (2018-2029)
8.3.5 India Clinical Research Organisation (CRO) Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Clinical Research Organisation (CRO) Market Size and Forecast (2018-2029)
8.3.7 Australia Clinical Research Organisation (CRO) Market Size and Forecast (2018-2029)

9 South America
9.1 South America Clinical Research Organisation (CRO) Consumption Value by Type (2018-2029)
9.2 South America Clinical Research Organisation (CRO) Consumption Value by Application (2018-2029)
9.3 South America Clinical Research Organisation (CRO) Market Size by Country
9.3.1 South America Clinical Research Organisation (CRO) Consumption Value by Country (2018-2029)
9.3.2 Brazil Clinical Research Organisation (CRO) Market Size and Forecast (2018-2029)
9.3.3 Argentina Clinical Research Organisation (CRO) Market Size and Forecast (2018-2029)

10 Middle East & Africa
10.1 Middle East & Africa Clinical Research Organisation (CRO) Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Clinical Research Organisation (CRO) Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Clinical Research Organisation (CRO) Market Size by Country
10.3.1 Middle East & Africa Clinical Research Organisation (CRO) Consumption Value by Country (2018-2029)
10.3.2 Turkey Clinical Research Organisation (CRO) Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Clinical Research Organisation (CRO) Market Size and Forecast (2018-2029)
10.3.4 UAE Clinical Research Organisation (CRO) Market Size and Forecast (2018-2029)

11 Market Dynamics
11.1 Clinical Research Organisation (CRO) Market Drivers
11.2 Clinical Research Organisation (CRO) Market Restraints
11.3 Clinical Research Organisation (CRO) Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry

12 Industry Chain Analysis
12.1 Clinical Research Organisation (CRO) Industry Chain
12.2 Clinical Research Organisation (CRO) Upstream Analysis
12.3 Clinical Research Organisation (CRO) Midstream Analysis
12.4 Clinical Research Organisation (CRO) Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Clinical Research Organisation (CRO) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Clinical Research Organisation (CRO) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Clinical Research Organisation (CRO) Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Clinical Research Organisation (CRO) Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Charles River Laboratories Company Information, Head Office, and Major Competitors
Table 6. Charles River Laboratories Major Business
Table 7. Charles River Laboratories Clinical Research Organisation (CRO) Product and Solutions
Table 8. Charles River Laboratories Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Charles River Laboratories Recent Developments and Future Plans
Table 10. IQVIA Company Information, Head Office, and Major Competitors
Table 11. IQVIA Major Business
Table 12. IQVIA Clinical Research Organisation (CRO) Product and Solutions
Table 13. IQVIA Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. IQVIA Recent Developments and Future Plans
Table 15. LabCorp Company Information, Head Office, and Major Competitors
Table 16. LabCorp Major Business
Table 17. LabCorp Clinical Research Organisation (CRO) Product and Solutions
Table 18. LabCorp Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. LabCorp Recent Developments and Future Plans
Table 20. Domainex Company Information, Head Office, and Major Competitors
Table 21. Domainex Major Business
Table 22. Domainex Clinical Research Organisation (CRO) Product and Solutions
Table 23. Domainex Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Domainex Recent Developments and Future Plans
Table 25. Evotec AG Company Information, Head Office, and Major Competitors
Table 26. Evotec AG Major Business
Table 27. Evotec AG Clinical Research Organisation (CRO) Product and Solutions
Table 28. Evotec AG Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Evotec AG Recent Developments and Future Plans
Table 30. Genscript Biotech Company Information, Head Office, and Major Competitors
Table 31. Genscript Biotech Major Business
Table 32. Genscript Biotech Clinical Research Organisation (CRO) Product and Solutions
Table 33. Genscript Biotech Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Genscript Biotech Recent Developments and Future Plans
Table 35. GVK Biosciences Company Information, Head Office, and Major Competitors
Table 36. GVK Biosciences Major Business
Table 37. GVK Biosciences Clinical Research Organisation (CRO) Product and Solutions
Table 38. GVK Biosciences Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. GVK Biosciences Recent Developments and Future Plans
Table 40. Aurobindo Pharma Company Information, Head Office, and Major Competitors
Table 41. Aurobindo Pharma Major Business
Table 42. Aurobindo Pharma Clinical Research Organisation (CRO) Product and Solutions
Table 43. Aurobindo Pharma Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Aurobindo Pharma Recent Developments and Future Plans
Table 45. Eurofins Scientific Company Information, Head Office, and Major Competitors
Table 46. Eurofins Scientific Major Business
Table 47. Eurofins Scientific Clinical Research Organisation (CRO) Product and Solutions
Table 48. Eurofins Scientific Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Eurofins Scientific Recent Developments and Future Plans
Table 50. Reprocell Company Information, Head Office, and Major Competitors
Table 51. Reprocell Major Business
Table 52. Reprocell Clinical Research Organisation (CRO) Product and Solutions
Table 53. Reprocell Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Reprocell Recent Developments and Future Plans
Table 55. Dalton Pharma Company Information, Head Office, and Major Competitors
Table 56. Dalton Pharma Major Business
Table 57. Dalton Pharma Clinical Research Organisation (CRO) Product and Solutions
Table 58. Dalton Pharma Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Dalton Pharma Recent Developments and Future Plans
Table 60. NovAliX Company Information, Head Office, and Major Competitors
Table 61. NovAliX Major Business
Table 62. NovAliX Clinical Research Organisation (CRO) Product and Solutions
Table 63. NovAliX Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. NovAliX Recent Developments and Future Plans
Table 65. Jubilant Biosys Company Information, Head Office, and Major Competitors
Table 66. Jubilant Biosys Major Business
Table 67. Jubilant Biosys Clinical Research Organisation (CRO) Product and Solutions
Table 68. Jubilant Biosys Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Jubilant Biosys Recent Developments and Future Plans
Table 70. Lupin Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 71. Lupin Pharmaceuticals Major Business
Table 72. Lupin Pharmaceuticals Clinical Research Organisation (CRO) Product and Solutions
Table 73. Lupin Pharmaceuticals Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Lupin Pharmaceuticals Recent Developments and Future Plans
Table 75. Piramal Pharma Company Information, Head Office, and Major Competitors
Table 76. Piramal Pharma Major Business
Table 77. Piramal Pharma Clinical Research Organisation (CRO) Product and Solutions
Table 78. Piramal Pharma Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Piramal Pharma Recent Developments and Future Plans
Table 80. Sun Pharmaceutical Company Information, Head Office, and Major Competitors
Table 81. Sun Pharmaceutical Major Business
Table 82. Sun Pharmaceutical Clinical Research Organisation (CRO) Product and Solutions
Table 83. Sun Pharmaceutical Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Sun Pharmaceutical Recent Developments and Future Plans
Table 85. Sai Ganga Panakeia Company Information, Head Office, and Major Competitors
Table 86. Sai Ganga Panakeia Major Business
Table 87. Sai Ganga Panakeia Clinical Research Organisation (CRO) Product and Solutions
Table 88. Sai Ganga Panakeia Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Sai Ganga Panakeia Recent Developments and Future Plans
Table 90. Vitas Pharma Company Information, Head Office, and Major Competitors
Table 91. Vitas Pharma Major Business
Table 92. Vitas Pharma Clinical Research Organisation (CRO) Product and Solutions
Table 93. Vitas Pharma Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. Vitas Pharma Recent Developments and Future Plans
Table 95. Pharmaron Beijing Company Information, Head Office, and Major Competitors
Table 96. Pharmaron Beijing Major Business
Table 97. Pharmaron Beijing Clinical Research Organisation (CRO) Product and Solutions
Table 98. Pharmaron Beijing Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 99. Pharmaron Beijing Recent Developments and Future Plans
Table 100. WuXi AppTec Company Information, Head Office, and Major Competitors
Table 101. WuXi AppTec Major Business
Table 102. WuXi AppTec Clinical Research Organisation (CRO) Product and Solutions
Table 103. WuXi AppTec Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 104. WuXi AppTec Recent Developments and Future Plans
Table 105. Asymchem Laboratories Company Information, Head Office, and Major Competitors
Table 106. Asymchem Laboratories Major Business
Table 107. Asymchem Laboratories Clinical Research Organisation (CRO) Product and Solutions
Table 108. Asymchem Laboratories Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 109. Asymchem Laboratories Recent Developments and Future Plans
Table 110. Porton Pharma Company Information, Head Office, and Major Competitors
Table 111. Porton Pharma Major Business
Table 112. Porton Pharma Clinical Research Organisation (CRO) Product and Solutions
Table 113. Porton Pharma Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 114. Porton Pharma Recent Developments and Future Plans
Table 115. ChemPartner Company Information, Head Office, and Major Competitors
Table 116. ChemPartner Major Business
Table 117. ChemPartner Clinical Research Organisation (CRO) Product and Solutions
Table 118. ChemPartner Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. ChemPartner Recent Developments and Future Plans
Table 120. Hangzhou Tigermed Company Information, Head Office, and Major Competitors
Table 121. Hangzhou Tigermed Major Business
Table 122. Hangzhou Tigermed Clinical Research Organisation (CRO) Product and Solutions
Table 123. Hangzhou Tigermed Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 124. Hangzhou Tigermed Recent Developments and Future Plans
Table 125. Global Clinical Research Organisation (CRO) Revenue (USD Million) by Players (2018-2023)
Table 126. Global Clinical Research Organisation (CRO) Revenue Share by Players (2018-2023)
Table 127. Breakdown of Clinical Research Organisation (CRO) by Company Type (Tier 1, Tier 2, and Tier 3)
Table 128. Market Position of Players in Clinical Research Organisation (CRO), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 129. Head Office of Key Clinical Research Organisation (CRO) Players
Table 130. Clinical Research Organisation (CRO) Market: Company Product Type Footprint
Table 131. Clinical Research Organisation (CRO) Market: Company Product Application Footprint
Table 132. Clinical Research Organisation (CRO) New Market Entrants and Barriers to Market Entry
Table 133. Clinical Research Organisation (CRO) Mergers, Acquisition, Agreements, and Collaborations
Table 134. Global Clinical Research Organisation (CRO) Consumption Value (USD Million) by Type (2018-2023)
Table 135. Global Clinical Research Organisation (CRO) Consumption Value Share by Type (2018-2023)
Table 136. Global Clinical Research Organisation (CRO) Consumption Value Forecast by Type (2024-2029)
Table 137. Global Clinical Research Organisation (CRO) Consumption Value by Application (2018-2023)
Table 138. Global Clinical Research Organisation (CRO) Consumption Value Forecast by Application (2024-2029)
Table 139. North America Clinical Research Organisation (CRO) Consumption Value by Type (2018-2023) & (USD Million)
Table 140. North America Clinical Research Organisation (CRO) Consumption Value by Type (2024-2029) & (USD Million)
Table 141. North America Clinical Research Organisation (CRO) Consumption Value by Application (2018-2023) & (USD Million)
Table 142. North America Clinical Research Organisation (CRO) Consumption Value by Application (2024-2029) & (USD Million)
Table 143. North America Clinical Research Organisation (CRO) Consumption Value by Country (2018-2023) & (USD Million)
Table 144. North America Clinical Research Organisation (CRO) Consumption Value by Country (2024-2029) & (USD Million)
Table 145. Europe Clinical Research Organisation (CRO) Consumption Value by Type (2018-2023) & (USD Million)
Table 146. Europe Clinical Research Organisation (CRO) Consumption Value by Type (2024-2029) & (USD Million)
Table 147. Europe Clinical Research Organisation (CRO) Consumption Value by Application (2018-2023) & (USD Million)
Table 148. Europe Clinical Research Organisation (CRO) Consumption Value by Application (2024-2029) & (USD Million)
Table 149. Europe Clinical Research Organisation (CRO) Consumption Value by Country (2018-2023) & (USD Million)
Table 150. Europe Clinical Research Organisation (CRO) Consumption Value by Country (2024-2029) & (USD Million)
Table 151. Asia-Pacific Clinical Research Organisation (CRO) Consumption Value by Type (2018-2023) & (USD Million)
Table 152. Asia-Pacific Clinical Research Organisation (CRO) Consumption Value by Type (2024-2029) & (USD Million)
Table 153. Asia-Pacific Clinical Research Organisation (CRO) Consumption Value by Application (2018-2023) & (USD Million)
Table 154. Asia-Pacific Clinical Research Organisation (CRO) Consumption Value by Application (2024-2029) & (USD Million)
Table 155. Asia-Pacific Clinical Research Organisation (CRO) Consumption Value by Region (2018-2023) & (USD Million)
Table 156. Asia-Pacific Clinical Research Organisation (CRO) Consumption Value by Region (2024-2029) & (USD Million)
Table 157. South America Clinical Research Organisation (CRO) Consumption Value by Type (2018-2023) & (USD Million)
Table 158. South America Clinical Research Organisation (CRO) Consumption Value by Type (2024-2029) & (USD Million)
Table 159. South America Clinical Research Organisation (CRO) Consumption Value by Application (2018-2023) & (USD Million)
Table 160. South America Clinical Research Organisation (CRO) Consumption Value by Application (2024-2029) & (USD Million)
Table 161. South America Clinical Research Organisation (CRO) Consumption Value by Country (2018-2023) & (USD Million)
Table 162. South America Clinical Research Organisation (CRO) Consumption Value by Country (2024-2029) & (USD Million)
Table 163. Middle East & Africa Clinical Research Organisation (CRO) Consumption Value by Type (2018-2023) & (USD Million)
Table 164. Middle East & Africa Clinical Research Organisation (CRO) Consumption Value by Type (2024-2029) & (USD Million)
Table 165. Middle East & Africa Clinical Research Organisation (CRO) Consumption Value by Application (2018-2023) & (USD Million)
Table 166. Middle East & Africa Clinical Research Organisation (CRO) Consumption Value by Application (2024-2029) & (USD Million)
Table 167. Middle East & Africa Clinical Research Organisation (CRO) Consumption Value by Country (2018-2023) & (USD Million)
Table 168. Middle East & Africa Clinical Research Organisation (CRO) Consumption Value by Country (2024-2029) & (USD Million)
Table 169. Clinical Research Organisation (CRO) Raw Material
Table 170. Key Suppliers of Clinical Research Organisation (CRO) Raw Materials
List of Figures
Figure 1. Clinical Research Organisation (CRO) Picture
Figure 2. Global Clinical Research Organisation (CRO) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Clinical Research Organisation (CRO) Consumption Value Market Share by Type in 2022
Figure 4. Small molecules
Figure 5. Biologics
Figure 6. Global Clinical Research Organisation (CRO) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Clinical Research Organisation (CRO) Consumption Value Market Share by Application in 2022
Figure 8. Pharmaceutical Company Picture
Figure 9. Research Institute Picture
Figure 10. Other Picture
Figure 11. Global Clinical Research Organisation (CRO) Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Clinical Research Organisation (CRO) Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Market Clinical Research Organisation (CRO) Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 14. Global Clinical Research Organisation (CRO) Consumption Value Market Share by Region (2018-2029)
Figure 15. Global Clinical Research Organisation (CRO) Consumption Value Market Share by Region in 2022
Figure 16. North America Clinical Research Organisation (CRO) Consumption Value (2018-2029) & (USD Million)
Figure 17. Europe Clinical Research Organisation (CRO) Consumption Value (2018-2029) & (USD Million)
Figure 18. Asia-Pacific Clinical Research Organisation (CRO) Consumption Value (2018-2029) & (USD Million)
Figure 19. South America Clinical Research Organisation (CRO) Consumption Value (2018-2029) & (USD Million)
Figure 20. Middle East and Africa Clinical Research Organisation (CRO) Consumption Value (2018-2029) & (USD Million)
Figure 21. Global Clinical Research Organisation (CRO) Revenue Share by Players in 2022
Figure 22. Clinical Research Organisation (CRO) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 23. Global Top 3 Players Clinical Research Organisation (CRO) Market Share in 2022
Figure 24. Global Top 6 Players Clinical Research Organisation (CRO) Market Share in 2022
Figure 25. Global Clinical Research Organisation (CRO) Consumption Value Share by Type (2018-2023)
Figure 26. Global Clinical Research Organisation (CRO) Market Share Forecast by Type (2024-2029)
Figure 27. Global Clinical Research Organisation (CRO) Consumption Value Share by Application (2018-2023)
Figure 28. Global Clinical Research Organisation (CRO) Market Share Forecast by Application (2024-2029)
Figure 29. North America Clinical Research Organisation (CRO) Consumption Value Market Share by Type (2018-2029)
Figure 30. North America Clinical Research Organisation (CRO) Consumption Value Market Share by Application (2018-2029)
Figure 31. North America Clinical Research Organisation (CRO) Consumption Value Market Share by Country (2018-2029)
Figure 32. United States Clinical Research Organisation (CRO) Consumption Value (2018-2029) & (USD Million)
Figure 33. Canada Clinical Research Organisation (CRO) Consumption Value (2018-2029) & (USD Million)
Figure 34. Mexico Clinical Research Organisation (CRO) Consumption Value (2018-2029) & (USD Million)
Figure 35. Europe Clinical Research Organisation (CRO) Consumption Value Market Share by Type (2018-2029)
Figure 36. Europe Clinical Research Organisation (CRO) Consumption Value Market Share by Application (2018-2029)
Figure 37. Europe Clinical Research Organisation (CRO) Consumption Value Market Share by Country (2018-2029)
Figure 38. Germany Clinical Research Organisation (CRO) Consumption Value (2018-2029) & (USD Million)
Figure 39. France Clinical Research Organisation (CRO) Consumption Value (2018-2029) & (USD Million)
Figure 40. United Kingdom Clinical Research Organisation (CRO) Consumption Value (2018-2029) & (USD Million)
Figure 41. Russia Clinical Research Organisation (CRO) Consumption Value (2018-2029) & (USD Million)
Figure 42. Italy Clinical Research Organisation (CRO) Consumption Value (2018-2029) & (USD Million)
Figure 43. Asia-Pacific Clinical Research Organisation (CRO) Consumption Value Market Share by Type (2018-2029)
Figure 44. Asia-Pacific Clinical Research Organisation (CRO) Consumption Value Market Share by Application (2018-2029)
Figure 45. Asia-Pacific Clinical Research Organisation (CRO) Consumption Value Market Share by Region (2018-2029)
Figure 46. China Clinical Research Organisation (CRO) Consumption Value (2018-2029) & (USD Million)
Figure 47. Japan Clinical Research Organisation (CRO) Consumption Value (2018-2029) & (USD Million)
Figure 48. South Korea Clinical Research Organisation (CRO) Consumption Value (2018-2029) & (USD Million)
Figure 49. India Clinical Research Organisation (CRO) Consumption Value (2018-2029) & (USD Million)
Figure 50. Southeast Asia Clinical Research Organisation (CRO) Consumption Value (2018-2029) & (USD Million)
Figure 51. Australia Clinical Research Organisation (CRO) Consumption Value (2018-2029) & (USD Million)
Figure 52. South America Clinical Research Organisation (CRO) Consumption Value Market Share by Type (2018-2029)
Figure 53. South America Clinical Research Organisation (CRO) Consumption Value Market Share by Application (2018-2029)
Figure 54. South America Clinical Research Organisation (CRO) Consumption Value Market Share by Country (2018-2029)
Figure 55. Brazil Clinical Research Organisation (CRO) Consumption Value (2018-2029) & (USD Million)
Figure 56. Argentina Clinical Research Organisation (CRO) Consumption Value (2018-2029) & (USD Million)
Figure 57. Middle East and Africa Clinical Research Organisation (CRO) Consumption Value Market Share by Type (2018-2029)
Figure 58. Middle East and Africa Clinical Research Organisation (CRO) Consumption Value Market Share by Application (2018-2029)
Figure 59. Middle East and Africa Clinical Research Organisation (CRO) Consumption Value Market Share by Country (2018-2029)
Figure 60. Turkey Clinical Research Organisation (CRO) Consumption Value (2018-2029) & (USD Million)
Figure 61. Saudi Arabia Clinical Research Organisation (CRO) Consumption Value (2018-2029) & (USD Million)
Figure 62. UAE Clinical Research Organisation (CRO) Consumption Value (2018-2029) & (USD Million)
Figure 63. Clinical Research Organisation (CRO) Market Drivers
Figure 64. Clinical Research Organisation (CRO) Market Restraints
Figure 65. Clinical Research Organisation (CRO) Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Clinical Research Organisation (CRO) in 2022
Figure 68. Manufacturing Process Analysis of Clinical Research Organisation (CRO)
Figure 69. Clinical Research Organisation (CRO) Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Charles River Laboratories
IQVIA
LabCorp
Domainex
Evotec AG
Genscript Biotech
GVK Biosciences
Aurobindo Pharma
Eurofins Scientific
Reprocell
Dalton Pharma
NovAliX
Jubilant Biosys
Lupin Pharmaceuticals
Piramal Pharma
Sun Pharmaceutical
Sai Ganga Panakeia
Vitas Pharma
Pharmaron Beijing
WuXi AppTec
Asymchem Laboratories
Porton Pharma
ChemPartner
Hangzhou Tigermed
jiaGou

Add To Cart

gouMai

Buy Now